Drug recall · December 9, 2020
Tizanidine Tablets recall
Why: Failed Dissolution Specifications; Out of Specification (low) results were obtained.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tizanidine Tablets, USP 4mg, Rx Only, 150 Tablets per Bottle, Manufactured by Alkem Laboratories Ltd, Mumbai - 400 013, INDIA, Distributed by: Ascend Laboratories, LLC Parsippany, NJ 07054, NDC: 67877-614-15.
- Lots / codes
Lot #19143017, Exp. 05/31/2021
- Quantity
- 1200 bottles
- Company
- Ascend Laboratories LLC, Parsippany, NJ
- Distribution
- MI
- Initiated
- November 24, 2020 · Voluntary: Firm initiated
- Classified
- December 22, 2020
- Reported
- December 9, 2020
- Ended
- April 11, 2023
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tizanidine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.